Old Drugs, New Uses

被引：0

作者：

da Fonseca, Marcio A. ^{[1
]}

Casamassimo, Paul ^{[2
]}

机构：

[1] Univ Washington, Grad Program, Dept Pediat Dent, Ctr Pediat Dent, Seattle, WA 98195 USA

[2] Ohio State Univ, Coll Dent, Nationwide Childrens Hosp, Div Pediat Dent, Columbus, OH 43210 USA

来源：

PEDIATRIC DENTISTRY | 2011年 / 33卷 / 01期

关键词：

PHARMACOLOGY; PEDIATRIC DENTISTRY; HOSPITAL DENTISTRY; CHILDREN WITH SPECIAL HEALTH CARE NEEDS; INTRAVENOUS IMMUNOGLOBULIN; ANTIEPILEPTIC DRUGS; BOTULINUM TOXIN; THERAPY; THALIDOMIDE; MANAGEMENT; DISORDERS; CHILDREN; METHOTREXATE; HYDROXYUREA;

D O I：

暂无

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

Advances in pediatric health care have prolonged lives and improved the quality of life for children and adolescents. These advances include not only high-tech devices and new medications but also re-application of available medications to take advantage of unexpected benefits which may not have been known previously or even side effects that can have therapeutic value for diseases and conditions refractory to other treatment. This review describes new uses for anti-epileptic medications, thalidomide, intravenous immuno globulin, hydroxyurea, methotrexate, botulinum toxin, bisphosphonates, and aspirin in the medical care of children. Methods of action and concerns for the pediatric dentist are described for children benefiting from these new applications. (Pediatr Dent 2011;33:67-74) Received August 19, 2009 I Last Revision November 14, 2009 I Accepted November 14, 2009

引用

页码：67 / 74

页数：8

共 46 条

[1] Clinical Review: Bisphosphonate Use in Childhood Osteoporosis
Bachrach, Laura K.
Ward, Leanne M.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) : 400 - 409
[2] How to manage osteoporosis in children
Bianchi, ML
[J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (06): : 991 - 1005
[3] National institutes of health consensus development conference statement: Hydroxyurea treatment for sickle cell disease
Brawley, Otis W.
Cornelius, Llewellyn J.
Edwards, Linda R.
Gamble, Vanessa Northington
Green, Bettye L.
Inturrisi, Charles
James, Andra H.
Laraque, Danielle
Mendez, Magda
Montoya, Carolyn J.
Pollock, Brad H.
Robinson, Lawrence
Scholnik, Aaron P.
Schori, Melissa
[J]. ANNALS OF INTERNAL MEDICINE, 2008, 148 (12) : 932 - +
[4] Botulinum toxin therapy: a tempting tool in the management of salivary secretory disorders
Capaccio, Pasquale
Torretta, Sara
Osio, Maurizio
Minorati, Davide
Ottaviani, Francesco
Sambataro, Giuseppe
Nascimbene, Cristina
Pignataro, Lorenzo
[J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2008, 29 (05) : 333 - 338
[5] Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review
Castillo, Heidi
Samson-Fang, Lisa
[J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2009, 51 (01) : 17 - 29
[6] Oxcarbazepine for self-mutilating bulimic patients
Cordas, Taki Athanassios
Tavares, Hermano
Calderoni, Douglas Motta
Stump, Gabriela Viegas
Ribeiro, Rafael Bernardon
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 (06) : 769 - 771
[7] da Fonseca MA, 2007, PEDIATR DENT, V29, P159
[8] Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
Darabi, K
Abdel-Wahab, O
Dzik, WH
[J]. TRANSFUSION, 2006, 46 (05) : 741 - 753
[9] Botulinum toxin in paediatric urology: a systematic literature review
DasGupta, Ranan
Murphy, Feilim Liam
[J]. PEDIATRIC SURGERY INTERNATIONAL, 2009, 25 (01) : 19 - 23
[10] Oral squamous cell carcinoma during long-term treatment with hydroxyurea
De Benedittis, M
Petruzzi, M
Giardina, C
Lo Muzio, L
Favia, G
Serpico, R
[J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (06) : 605 - 607

← 1 2 3 4 5 →